DMD

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on March 13, 2008; DOI: 10.1124/dmd.107.019729


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.107.019729v1
36/6/1080    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hashita, T.
Right arrow Articles by Nemoto, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hashita, T.
Right arrow Articles by Nemoto, N.


Received for publication November 15, 2007.
Revised March 7, 2008.
Accepted for publication March 10, 2008.

FoxA2-mediated regulation of female-predominant expression of the mouse Cyp2b9 gene

Tadahiro Hashita 1, Tsutomu Sakuma 1, Mami Akada 1, Asuka Nakajima 1, Hirofumi Yamahara 1, Sumiyo Ito 1, Hidekazu Takesako 1, Nobuo Nemoto 1*

1 University of Toyama

* Address correspondence to: E-mail: nnemoto{at}pha.u-toyama.ac.jp

Abstract

ABSTRACT The regulation mechanism of female-predominant expression of the mouse Cyp2b9 gene was investigated in vivo and in vitro. Luciferase reporter assay revealed that the -234/-194 region of the Cyp2b9 gene may be responsible for sexually dimorphic expression. There is a predicted FoxA2(HNF3{beta})-binding site in this region. Chromatin immunoprecipitation assay indicated that the binding protein to the site was FoxA2 in 5-week-old female mice, while this protein was found in both sexes at 3 weeks old, in accordance with our previous observation on the developmental expression of this gene. Mutation of the predicted FoxA2 site in the reporter construct containing the -234/+18 fragment led to complete elimination of luciferase activity, but deletion of the -234/-194 region resulted in considerable transcriptional activity, suggesting that, by mutating the FoxA2-binding site, a potent suppressor might bind to eliminate activity while, by deleting this region, it could not. Sexually dimorphic secretion of growth hormone is involved in female-predominant expression of the gene, and the -234/-194 region was also responsible for suppressing the expression by male-type secretion.


Key words: CYP expression, CYP gene regulation, CYP2B, gender differences, hormonal regulation, JAK-STAT, sexual dimorphism





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.